Understanding patient and provider preferences in management of metastatic renal cell carcinoma (mRCC)

被引：0
|
作者：
Yazdanpanah, Omid
Benjamin, David Joseph
Vosoughi, Elham
Raad, Ali
Popal, Medina
Kongtim, Piyanuch
Mar, Nataliya
Rezazadeh, Arash
机构：
[1] Univ Calif Irvine, Div Hematol Oncol, Orange, CA 92668 USA
[2] Hoag Family Canc Inst, Newport Beach, CA USA
[3] Univ Calif San Francisco, San Francisco, CA 94143 USA
[4] Chao Comprehens Canc Ctr, Stern Ctr Canc Clin Trials & Res, Orange, CA USA
[5] Univ Calif Irvine, Orange, CA 92668 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16530
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Active surveillance (AS) in the management of patients (pts) with metastatic renal cell carcinoma (mRCC).
    Ivanyi, Philipp
    Eggers, Hendik
    Seidel, Christoph Alexander
    Reuter, Christoph
    Ganser, Arnold
    Gruenwald, Viktor
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [2] Metastatic renal cell carcinoma (MRCC): Responses to different immunotherapies
    Landonio, G
    Baiocchi, C
    Ferrari, M
    Gottardi, O
    Majno, M
    Scanzi, F
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 468 - 468
  • [3] Expression of VHL and SRC in metastatic renal cell carcinoma (mRCC).
    Luo, Jia
    Podolak, Jennifer
    Degnin, Catherine
    Chen, Yiyi
    Robinson, Kyle William
    Pukay, Marina
    Schilling, Amy
    Poage, Cara
    Thomas, George V.
    Ryan, Christopher W.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [4] Clinical and Pathological Complete Remission in a Patient With Metastatic Renal Cell Carcinoma (mRCC) Treated With Sunitinib: Is mRCC Curable With Targeted Therapy?
    Shah, Amishi Y.
    Karam, Jose A.
    Lim, Zita D.
    Ng, Chaan S.
    Tannir, Nizar M.
    UROLOGY CASE REPORTS, 2015, 3 (02) : 18 - 20
  • [5] Role of cytoreductive nephrectomy (CN) in metastatic renal cell carcinoma (mRCC).
    Ghatalia, Pooja
    Handorf, Elizabeth A.
    Deng, Mengying
    Zibelman, Matthew R.
    Abbosh, Philip
    Anari, Fern
    Greenberg, Richard E.
    Viterbo, Rosalia
    Chen, David
    Smaldone, Marc C.
    Kutikov, Alexander
    Geynisman, Daniel M.
    Uzzo, Robert Guy
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [6] Australian Treatment Practices for Patients with Metastatic Renal Cell Carcinoma (MRCC)
    Liow, Elizabeth
    Baenziger, Olivia
    Corrente, Claudia
    Law, Nicholas
    Azad, Arun
    Shapiro, Julia
    Shapiro, Jeremy
    Weickhardt, Andrew
    Schmidt, Andrew
    Parnis, Francis
    Wong, Shirley
    Parente, Phillip
    Anton, Angelyn
    Pezaro, Carmel
    Tran, Ben
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2019, 15 : 55 - 55
  • [7] Outcomes of "real world" treatment for metastatic renal cell carcinoma (mRCC).
    Harrison, Michael Roger
    George, Daniel J.
    Walker, Mark S.
    Hudson, Lori L.
    Chen, Connie
    Korytowsky, Beata
    Stepanski, Edward J.
    Abernethy, Amy P.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [8] PATIENT PREFERENCE FOR TIVOZANIB HYDROCHLORIDE OR SUNITINIB IN THE TREATMENT OF METASTATIC RENAL CELL CARCINOMA (MRCC): TAURUS STUDY
    Escudier, B.
    Steelman, L.
    Cesic, D.
    Berkenblit, A.
    ANNALS OF ONCOLOGY, 2012, 23 : 293 - 293
  • [9] Ixabepilone (BMS-247550) and metastatic renal cell carcinoma (mRCC)
    Huang, H.
    Menefee, M. E.
    Edgerly, M.
    Kotz, H.
    Poruchynsky, M.
    Stein, W. D.
    Bates, S. E.
    Fojo, A. T.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [10] PATTERNS OF CARE IN AUSTRALIAN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (MRCC)
    Dai, D.
    Kanjanapan, Y.
    Kwan, E.
    Yip, D.
    Lawrentschuk, N.
    Andrews, M.
    Davis, I. D.
    Azad, A.
    Rosenthal, M.
    Wong, S.
    Arifeen, S.
    Alam, M.
    Gibbs, P.
    Tran, B.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 : 33 - 33
12345